Pregnane X Receptor (PXR) Agonist Rifampicin Effects on Glucose, Lipid and Hormone Homeostasis

Clinical trial NCT00985270 · COMPLETED

Trial details

NCT number: NCT00985270
Sponsor: University of Oulu
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Glucose Tolerance

Start date: 2009-09-01
Primary completion: 2010-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.